Worth reading
69In focus
Scored from 2 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
100000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Large-scale exercise of the 17th Stock Acquisition Rights issued through a third-party allotment (with an option to revise the exercise price)
Who receives how much
Shares delivered since the beginning of the month: 100,000 shares (100,000 new shares and 0 treasury shares transferred)
Cantor Fitzgerald Europe (the allottee at the time of issuance on 26 December 2025)
The lower thin line represents the existing number of shares to which these shares will be added.
Terms of the stock acquisition rights
Exercise price
¥1,070 (12 May 2026). Details of the adjustment provisions and the floor price: not disclosed
Number of Stock Acquisition Rights
Total issued: 1,608 rights; exercised since the beginning of the month: 1,000 rights; currently unexercised: 608 rights
Most recent equity financing
Timing 26 December 2025 / Type Issuance of the 17th Stock Acquisition Rights (with an option to revise the exercise price) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Large-scale exercise of the 17th Stock Acquisition Rights issued through a third-party allotment (with an option to revise the exercise price) |
| Number of shares to be issued or disposed of | Shares delivered since the beginning of the month: 100,000 shares (100,000 new shares and 0 treasury shares transferred) |
| Intended allottee | Cantor Fitzgerald Europe (the allottee at the time of issuance on 26 December 2025) |
| Total number of issued shares | 8,912,700 shares (including 61,508 treasury shares) → Not disclosed |
| Exercise price | ¥1,070 (12 May 2026). Details of the adjustment provisions and the floor price: not disclosed |
| Number of Stock Acquisition Rights | Total issued: 1,608 rights; exercised since the beginning of the month: 1,000 rights; currently unexercised: 608 rights |
| Most recent equity financing | Timing 26 December 2025 / Type Issuance of the 17th Stock Acquisition Rights (with an option to revise the exercise price) / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This disclosure was made because a large-scale exercise occurred. No specific reason for the exercise was stated.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.